Longeveron IncNASDAQ:LGVN
- LAST PRICE1.8900
- TODAY'S CHANGE (%)0.0200 (1.0695%)
- Bid / Lots1.8800/ 18
- Ask / Lots1.9200/ 51
- Open / Previous Close1.8500 / 1.8700
- Day Range
- 52 Week Range
- Volume197,327
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LGVN |
|---|---|---|
| 09:32 ET | 3277 | 1.8272 |
| 09:33 ET | 100 | 1.835 |
| 09:35 ET | 1325 | 1.8219 |
| 09:37 ET | 550 | 1.83 |
| 09:39 ET | 310 | 1.835 |
| 09:42 ET | 111 | 1.8407 |
| 09:44 ET | 907 | 1.86 |
| 09:50 ET | 1467 | 1.87 |
| 09:57 ET | 300 | 1.875 |
| 10:00 ET | 200 | 1.88 |
| 10:02 ET | 700 | 1.86 |
| 10:04 ET | 8980 | 1.85 |
| 10:06 ET | 5566 | 1.85 |
| 10:09 ET | 1464 | 1.84 |
| 10:13 ET | 125 | 1.84 |
| 10:18 ET | 431 | 1.8408 |
| 10:20 ET | 6019 | 1.84 |
| 10:26 ET | 300 | 1.8458 |
| 10:27 ET | 5942 | 1.85 |
| 10:29 ET | 1000 | 1.84 |
| 10:31 ET | 1425 | 1.8406 |
| 10:33 ET | 116 | 1.8411 |
| 10:36 ET | 1000 | 1.84 |
| 10:38 ET | 5476 | 1.8601 |
| 10:40 ET | 10590 | 1.85 |
| 10:44 ET | 1886 | 1.8706 |
| 10:47 ET | 3000 | 1.8701 |
| 10:49 ET | 5000 | 1.8703 |
| 10:54 ET | 2100 | 1.875 |
| 10:56 ET | 580 | 1.87 |
| 10:58 ET | 100 | 1.87 |
| 11:03 ET | 100 | 1.88 |
| 11:07 ET | 600 | 1.8756 |
| 11:09 ET | 200 | 1.872 |
| 11:12 ET | 374 | 1.87 |
| 11:18 ET | 300 | 1.875 |
| 11:20 ET | 400 | 1.88 |
| 11:21 ET | 100 | 1.87 |
| 11:23 ET | 200 | 1.875 |
| 11:25 ET | 613 | 1.875 |
| 11:27 ET | 200 | 1.875 |
| 11:30 ET | 1200 | 1.875 |
| 11:32 ET | 600 | 1.875 |
| 11:34 ET | 410 | 1.875 |
| 11:36 ET | 300 | 1.875 |
| 11:38 ET | 1100 | 1.875 |
| 11:39 ET | 100 | 1.875 |
| 11:41 ET | 200 | 1.875 |
| 11:54 ET | 100 | 1.87 |
| 11:57 ET | 100 | 1.875 |
| 12:03 ET | 6600 | 1.895 |
| 12:06 ET | 2200 | 1.9094 |
| 12:08 ET | 1200 | 1.905 |
| 12:10 ET | 1986 | 1.9 |
| 12:12 ET | 2305 | 1.9095 |
| 12:14 ET | 735 | 1.9085 |
| 12:15 ET | 192 | 1.9007 |
| 12:17 ET | 110 | 1.9 |
| 12:19 ET | 800 | 1.9 |
| 12:21 ET | 100 | 1.905 |
| 12:24 ET | 2804 | 1.9003 |
| 12:26 ET | 7537 | 1.88 |
| 12:28 ET | 1000 | 1.89 |
| 12:37 ET | 500 | 1.895 |
| 12:39 ET | 1071 | 1.8901 |
| 12:42 ET | 1422 | 1.89 |
| 12:44 ET | 200 | 1.89 |
| 12:48 ET | 2100 | 1.9 |
| 12:50 ET | 100 | 1.901 |
| 12:51 ET | 440 | 1.9007 |
| 12:53 ET | 200 | 1.9 |
| 01:18 ET | 5349 | 1.900672 |
| 01:20 ET | 1908 | 1.9 |
| 01:26 ET | 997 | 1.8993 |
| 01:29 ET | 210 | 1.89 |
| 01:31 ET | 100 | 1.895 |
| 01:33 ET | 2200 | 1.9 |
| 01:36 ET | 100 | 1.895 |
| 01:38 ET | 783 | 1.9 |
| 01:40 ET | 1500 | 1.895 |
| 01:44 ET | 700 | 1.895 |
| 01:45 ET | 1200 | 1.89 |
| 01:47 ET | 2063 | 1.89 |
| 01:51 ET | 128 | 1.89 |
| 01:56 ET | 400 | 1.89 |
| 01:58 ET | 348 | 1.895 |
| 02:00 ET | 2625 | 1.895 |
| 02:02 ET | 1242 | 1.9 |
| 02:03 ET | 285 | 1.891 |
| 02:12 ET | 462 | 1.9 |
| 02:14 ET | 100 | 1.9 |
| 02:20 ET | 620 | 1.8964 |
| 02:21 ET | 697 | 1.9 |
| 02:23 ET | 100 | 1.8905 |
| 02:25 ET | 1176 | 1.8999 |
| 02:27 ET | 500 | 1.895 |
| 02:32 ET | 438 | 1.9 |
| 02:36 ET | 1500 | 1.895 |
| 02:39 ET | 250 | 1.89 |
| 02:45 ET | 1000 | 1.89 |
| 02:50 ET | 100 | 1.895 |
| 02:52 ET | 100 | 1.895 |
| 02:56 ET | 1752 | 1.9 |
| 02:57 ET | 144 | 1.9 |
| 03:01 ET | 100 | 1.898 |
| 03:03 ET | 500 | 1.8999 |
| 03:06 ET | 1600 | 1.8976 |
| 03:08 ET | 100 | 1.89 |
| 03:12 ET | 1000 | 1.89 |
| 03:24 ET | 1600 | 1.8904 |
| 03:26 ET | 706 | 1.89 |
| 03:28 ET | 2200 | 1.9 |
| 03:30 ET | 1000 | 1.895 |
| 03:33 ET | 906 | 1.8986 |
| 03:44 ET | 300 | 1.89 |
| 03:46 ET | 500 | 1.8992 |
| 03:53 ET | 1000 | 1.8946 |
| 03:55 ET | 500 | 1.891 |
| 03:57 ET | 1431 | 1.8933 |
| 04:00 ET | 22640 | 1.89 |
Nov 12, 2024
Press Release: Longeveron(R) Announces Third Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow JonesLongeveron(R) Announces Third Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 11, 2024
Press Release: Longeveron(R) Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC), from 9:05AM ET on Monday Nov 11, 2024 by Dow Jones
9:05AM ET on Monday Nov 11, 2024 by Dow JonesLongeveron(R) Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC), from 9:05AM ET on Monday Nov 11, 2024 by Dow Jones
9:05AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 4, 2024
Longeveron(R) to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024, from 4:05PM ET on Monday Nov 04, 2024 by Dow Jones
4:05PM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Longeveron Inc | 28.0M | -0.3x | --- |
Pluri Inc | 27.2M | -1.2x | --- |
Clene Inc. | 31.6M | -0.7x | --- |
IGC Pharma Inc | 27.6M | -1.9x | --- |
GeoVax Labs Inc | 27.8M | -0.3x | --- |
Eterna Therapeutics Inc | 26.7M | -0.1x | --- |
Company Information
Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. The Company is primarily focused on three pipeline indications, which include Hypoplastic Left Heart Syndrome (HLHS), Alzheimer’s disease (AD) and Aging-related Frailty. Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The Company has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.
Contact Information
- Headquarters
- 1951 NW 7th Ave, Ste 520MIAMI, FL, United States 33136
- Phone
- 305-302-7158
- Fax
- 302-674-5266
Executives
- Chairman of the Board, Co-Founder, Chief Science Officer
- Joshua Hare
- Chief Executive Officer, Director
- Wa'el Hashad
- Co-Founder, Director
- Donald Soffer
- Chief Financial Officer, Executive Vice President
- Lisa Locklear
- General Counsel, Corporate Secretary, International Executive Director
- Paul Lehr
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $28.0M |
|---|---|
Revenue (TTM) | $1.9M |
Shares Outstanding | 14.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.28 |
EPS | $-6.67 |
Book Value | $2.68 |
P/E Ratio | -0.3x |
Price/Sales (TTM) | 15.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -970.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
